WHO Expert Committee on Specifications for Pharmaceutical Preparations (Record no. 74916)

MARC details
000 -LEADER
fixed length control field 02953nam a2200373Ia 4500
001 - CONTROL NUMBER
control field 0000085759
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20171002054338.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m u
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 060721s2006 sz a sb i100 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9241209372
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10137826
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)70830413
040 ## - CATALOGING SOURCE
Original cataloging agency CaPaEBR
Transcribing agency CaPaEBR
050 14 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RA8
Item number .A247 2006eb
245 00 - TITLE STATEMENT
Title WHO Expert Committee on Specifications for Pharmaceutical Preparations
Medium [electronic resource] :
Remainder of title fortieth report.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Geneva :
Name of publisher, distributor, etc. World Health Organization,
Date of publication, distribution, etc. 2006.
300 ## - PHYSICAL DESCRIPTION
Extent x, 461 p. :
Other physical details ill.
490 1# - SERIES STATEMENT
Series statement WHO technical report series ;
Volume/sequential designation 937
500 ## - GENERAL NOTE
General note "WHO Expert Committee on Specifications for Pharmaceutical Preparations, Geneva, 24-28 October 2005"--P. vii.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references.
520 ## - SUMMARY, ETC.
Summary, etc. This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Annexes include: a list of available international chemical reference substances and international infrared spectra; supplementary guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms; updated supplementary guidelines on good manufacturing practices for the manufacture of herbal medicines; supplementary guidelines on good manufacturing practices for validation; good distribution practices for pharmaceutical products; a model quality assurance system for procurement agencies (recommendations for quality assurance systems focusing on prequalification of products and manufacturers, purchasing, storage and distribution of pharmaceutical products); multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability; a proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms; and additional guidance for organizations performing in vivo bioequivalence studies.
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction.
Place of reproduction Palo Alto, Calif. :
Agency responsible for reproduction ebrary,
Date of reproduction 2009.
Note about reproduction Available via World Wide Web.
-- Access may be limited to ebrary affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Standards
Form subdivision Congresses.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacopoeias
Form subdivision Congresses.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
General subdivision Quality control
Form subdivision Congresses.
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
Source of term local
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element World Health Organization.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element WHO Expert Committee on Specifications for Pharmaceutical Preparations
Number of part/section/meeting (40th :
Date of meeting or treaty signing 2005 :
Location of meeting Geneva, Switzerland)
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element ebrary, Inc.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Technical report series (World Health Organization) ;
Volume/sequential designation 937.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://site.ebrary.com/lib/daystar/Doc?id=10137826">http://site.ebrary.com/lib/daystar/Doc?id=10137826</a>
Public note An electronic book accessible through the World Wide Web; click to view
908 ## - PUT COMMAND PARAMETER (RLIN)
Put command parameter 170314
942 00 - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Electronic Book

No items available.